Axa S.A. Haemonetics Corp Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

A detailed history of Axa S.A. transactions in Haemonetics Corp stock. As of the latest transaction made, Axa S.A. holds 58,130 shares of HAE stock, worth $4.97 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

58,130

Previous 53,625 8.4%

Holding current value

$4.97 Million

Previous $4.44 Million 5.3%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$72.45 - $91.58 $326,387 - $412,567	4,505 Added 8.4%	58,130 $4.67 Million
Q2 2024 Aug 14, 2024	SELL	$81.24 - $97.37 $4,061 - $4,868	-50 Reduced 0.09%	53,625 $4.44 Million
Q1 2024 May 15, 2024	SELL	$71.24 - $85.35 $1,780 - $2,133	-25 Reduced 0.05%	53,675 $4.58 Million
Q4 2023 Jul 16, 2024	BUY	$80.59 - $92.61 $2,014 - $2,315	25 Added 0.05%	53,700 $4.59 Million
Q4 2023 Feb 14, 2024	BUY	$80.59 - $92.61 $137,003 - $157,437	1,700 Added 3.27%	53,700 $4.59 Million
Q3 2023 Nov 14, 2023	SELL	$82.56 - $93.49 $66,048 - $74,792	-800 Reduced 1.52%	52,000 $4.66 Million
Q2 2023 Aug 14, 2023	BUY	$80.84 - $89.45 $606,300 - $670,875	7,500 Added 16.56%	52,800 $4.5 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $3.3 Million - $4.1 Million	45,300 New	45,300 $3.75 Million
Q4 2021 Feb 14, 2022	SELL	$49.55 - $74.59 $222,975 - $335,655	-4,500 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$57.6 - $70.59 $288,000 - $352,950	-5,000 Reduced 52.63%	4,500 $318,000
Q3 2020 Nov 13, 2020	SELL	$75.65 - $93.58 $98,345 - $121,654	-1,300 Reduced 12.04%	9,500 $829,000
Q1 2020 May 15, 2020	BUY	$74.34 - $121.82 $802,872 - $1.32 Million	10,800 New	10,800 $1.08 Million
Q4 2017 Feb 13, 2018	SELL	$44.96 - $58.99 $953,152 - $1.25 Million	-21,200 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$40.38 - $44.87 $856,056 - $951,244	21,200	21,200 $951,000

Others Institutions Holding HAE

# of Institutions

333

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.39B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account